Add to ORKGTo assess the frequency of epilepsy in primary and secondary antiphospholipid syndrome (APS); to analyze the clinical and laboratory features characterizing those with epilepsy in a cohort of 538 patients with APS; and to find associated features that would suggest risk factors for epilepsy in APS
Background: Some immunologic mechanisms of epilepsy are cited in literature. The possibility that ep...
Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
Antiphospholipid syndrome (APS) is an autoimmune process that increases the risk of arterial and ven...
OBJECTIVE: To assess the frequency of epilepsy in primary and secondary antiphospholipid syndrome (A...
The antiphospholipid syndrome (APS) is defined by the presence of antiphospholipid antibodies (aPL),...
Antiphospholipid antibodies (aPL) have been most strongly associated with a syndrome (APS) character...
Objectives. To evaluate the frequency of seizures in primary antiphospholipid syndrome (PAPS) and th...
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by recurrent thrombotic event...
Anti-phospholipids syndrome (APS) is considered a non inflammatory auto-immune disease with a signif...
Antiphospholipid antibodies (aPL) have been associated with a variety of neurological disorders, mos...
<p>anti-β<sub>2</sub>GPI—anti-β2-glycoprotein-I; aCL—anticardiolipin; IgG—immunoglobulin G; IgA—immu...
Antiphospholipid syndrome (APS) is an autoimmune disease with recurrent thromboses and pregnancy co...
The antiphospholipid syndrome (APS) defines the clinical association between antiphospholipid antibo...
Antiphospholipid syndrome (APS) is an entity defined for the presence of antiphospholipid antib...
Background: Autoimmunity is believed to play an important causative role in the pathogenesis of epil...
Background: Some immunologic mechanisms of epilepsy are cited in literature. The possibility that ep...
Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
Antiphospholipid syndrome (APS) is an autoimmune process that increases the risk of arterial and ven...
OBJECTIVE: To assess the frequency of epilepsy in primary and secondary antiphospholipid syndrome (A...
The antiphospholipid syndrome (APS) is defined by the presence of antiphospholipid antibodies (aPL),...
Antiphospholipid antibodies (aPL) have been most strongly associated with a syndrome (APS) character...
Objectives. To evaluate the frequency of seizures in primary antiphospholipid syndrome (PAPS) and th...
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by recurrent thrombotic event...
Anti-phospholipids syndrome (APS) is considered a non inflammatory auto-immune disease with a signif...
Antiphospholipid antibodies (aPL) have been associated with a variety of neurological disorders, mos...
<p>anti-β<sub>2</sub>GPI—anti-β2-glycoprotein-I; aCL—anticardiolipin; IgG—immunoglobulin G; IgA—immu...
Antiphospholipid syndrome (APS) is an autoimmune disease with recurrent thromboses and pregnancy co...
The antiphospholipid syndrome (APS) defines the clinical association between antiphospholipid antibo...
Antiphospholipid syndrome (APS) is an entity defined for the presence of antiphospholipid antib...
Background: Autoimmunity is believed to play an important causative role in the pathogenesis of epil...
Background: Some immunologic mechanisms of epilepsy are cited in literature. The possibility that ep...
Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
Antiphospholipid syndrome (APS) is an autoimmune process that increases the risk of arterial and ven...